HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Abstract
The basic leucine zipper transcription factor CCAAT/enhancer binding protein-beta (C/EBPbeta) is expressed in many cell types, including keratinocytes. C/EBPbeta activity can be increased by phosphorylation through pathways stimulated by oncogenic Ras, although the biological implications of Ras-C/EBPbeta signaling are not currently understood. We report here that C/EBPbeta-nullizygous mice are completely refractory to skin tumor development induced by a variety of carcinogens and carcinogenesis protocols, including 7,12-dimethylbenz[a]anthracene-initiation/12-O-tetradecanoylphorbol 13-acetate promotion, that produce tumors containing oncogenic Ras mutations. No significant differences in TPA-induced epidermal keratinocyte proliferation were observed in C/EBPbeta-null versus wild-type mice. However, apoptosis was significantly elevated (17-fold) in the epidermal keratinocytes of 7,12-dimethylbenz[a]anthracene-treated C/EBPbeta-null mice compared with wild-type mice. In v-Ha-ras transgenic mice, C/EBPbeta deficiency also led to greatly reduced skin tumor multiplicity and size, providing additional evidence for a tumorigenesis pathway linking Ras and C/EBPbeta. Oncogenic Ras potently stimulated C/EBPbeta to activate a C/EBP-responsive promoter-reporter in keratinocytes and mutating an ERK1/2 phosphorylation site (T188) in C/EBPbeta abolished this Ras effect. Finally, we observed that C/EBPbeta participates in oncogenic Ras-induced transformation of NIH 3T3 cells. These findings indicate that C/EBPbeta has a critical role in Ras-mediated tumorigenesis and cell survival and implicate C/EBPbeta as a target for tumor inhibition.
AuthorsSongyun Zhu, Kyungsil Yoon, Esta Sterneck, Peter F Johnson, Robert C Smart
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 99 Issue 1 Pg. 207-12 (Jan 08 2002) ISSN: 0027-8424 [Print] United States
PMID11756662 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CCAAT-Enhancer-Binding Protein-beta
  • Carcinogens
  • Mutagens
  • 9,10-Dimethyl-1,2-benzanthracene
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Oncogene Protein p21(ras)
  • Bromodeoxyuridine
  • Tetradecanoylphorbol Acetate
Topics
  • 3T3 Cells
  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Apoptosis
  • Blotting, Western
  • Bromodeoxyuridine (pharmacology)
  • CCAAT-Enhancer-Binding Protein-beta (genetics, metabolism, physiology)
  • Carcinogens
  • Cell Division
  • Cell Survival
  • Genes, Reporter
  • Keratinocytes (cytology, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Mitogen-Activated Protein Kinase 1 (metabolism)
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases (metabolism)
  • Mutagens
  • Mutation
  • Oncogene Protein p21(ras) (genetics, physiology)
  • Phosphorylation
  • Signal Transduction
  • Skin Neoplasms (metabolism)
  • Tetradecanoylphorbol Acetate
  • Time Factors
  • Transcriptional Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: